Evidence map›Paper›PMID 36411396›Full record

ArticleDiabetologia2023

The impact of population-level HbA

Katherine G Young, Andrew P McGovern, Inês Barroso, Andrew T Hattersley, Angus G Jones, Beverley M Shields, Nicholas J Thomas, John M Dennis

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Diabetologia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Potential value streams of an integrated Canadian serosurveillance network.Canadian journal of public health = Revue canadienne de sante publique · 2026
    Article
  2. Article
  3. Observational
  4. Article
  5. Applications and prospects of biomaterials in diabetes management.Frontiers in bioengineering and biotechnology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. HbADiabetologia · 2023
    Article
  11. HbADiabetologia · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Katherine G YoungExeter Centre of Excellence in Diabetes (EXCEED), University of Exeter Medical School, Exeter, UK. k.young3@exeter.ac.uk.ORCID http://orcid.org/0000-0003-2570-3864
Andrew P McGovernExeter Centre of Excellence in Diabetes (EXCEED), University of Exeter Medical School, Exeter, UK.ORCID https://orcid.org/0000-0002-6833-9399
Inês BarrosoExeter Centre of Excellence in Diabetes (EXCEED), University of Exeter Medical School, Exeter, UK.ORCID https://orcid.org/0000-0001-5800-4520
Andrew T HattersleyExeter Centre of Excellence in Diabetes (EXCEED), University of Exeter Medical School, Exeter, UK.ORCID https://orcid.org/0000-0001-5620-473X
Angus G JonesExeter Centre of Excellence in Diabetes (EXCEED), University of Exeter Medical School, Exeter, UK.ORCID https://orcid.org/0000-0002-0883-7599
Beverley M ShieldsExeter Centre of Excellence in Diabetes (EXCEED), University of Exeter Medical School, Exeter, UK.ORCID https://orcid.org/0000-0003-3785-327X
Nicholas J ThomasExeter Centre of Excellence in Diabetes (EXCEED), University of Exeter Medical School, Exeter, UK.ORCID https://orcid.org/0000-0003-2513-7022
John M DennisExeter Centre of Excellence in Diabetes (EXCEED), University of Exeter Medical School, Exeter, UK.ORCID https://orcid.org/0000-0002-7171-732X
University of Exeter · GB

Funding

British Heart Foundation SP/19/6/34809Medical Research Council MC_PC_17228Medical Research Council MC_QA137853Medical Research Council MR/K005707/1Medical Research Council MR/N00633X/1Medical Research Council MR/W003988/1Wellcome Trust 220601/Z/20/Z
6 · The paper itself

Abstract

aims/hypothesisScreening programmes can detect cases of undiagnosed diabetes earlier than symptomatic or incidental diagnosis. However, the improvement in time to diagnosis achieved by screening programmes compared with routine clinical care is unclear. We aimed to use the UK Biobank population-based study to provide the first population-based estimate of the reduction in time to diabetes diagnosis that could be achieved by HbA

methodsWe studied UK Biobank participants aged 40-70 years with HbA

resultsIn total, 1.0% (1703/166,846) of participants without a diabetes diagnosis had undiagnosed diabetes based on calibrated HbA CONCLUSIONS/

interpretationOur population-based study shows that HbA

Indexed as

Delayed DiagnosisDiabetes MellitusAdultBiological Specimen BanksFemaleHumansKaplan-Meier EstimateMiddle AgedUnited KingdomDiabetesHbA1cPublic healthScreeningUK Biobank

Identifiers

PMID36411396
PMCPMC9807472
OpenAlexW4309668618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.